• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

安非他酮 XL 和依地普仑对成年重性抑郁障碍患者记忆和功能结局的影响:一项随机对照试验的结果。

The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial.

机构信息

Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada.

Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Centre for Addiction & Mental Health, Toronto, Ontario, Canada.

出版信息

Psychiatry Res. 2014 Dec 15;220(1-2):245-50. doi: 10.1016/j.psychres.2014.06.053. Epub 2014 Jul 10.

DOI:10.1016/j.psychres.2014.06.053
PMID:25124683
Abstract

Decrements in cognitive function are a common feature of Major Depressive Disorder (MDD), and whether distinct classes of antidepressants differentially affect memory in these individuals has not been sufficiently evaluated. In this study we sought to determine the effect of escitalopram and bupropion XL on memory and psychosocial function. Forty-one individuals (18-50 years) with MDD were enrolled in an 8-week, double-blind, double-dummy, randomized controlled comparative trial of bupropion XL and escitalopram. Thirty-six participants completed pre and post memory assessments. Verbal, non-verbal and working memory were evaluated with a comprehensive neuropsychological battery. Psychosocial function was assessed with the Sheehan Disability Scale and Endicott Work Productivity Scale. Escitalopram and bupropion XL significantly improved immediate as well as delayed verbal and nonverbal memory, global function (all p≤0.001), and work productivity (p=0.045), with no significant between-group differences. Improvement in immediate verbal memory exerted a direct influence on improvement in global function (p=0.006). Treatment with either escitalopram or bupropion XL was associated with improvement in memory and psychosocial function in adults with MDD.

摘要

认知功能下降是重度抑郁症(MDD)的一个常见特征,不同类别的抗抑郁药是否会对这些患者的记忆产生不同的影响尚未得到充分评估。在这项研究中,我们旨在确定艾司西酞普兰和安非他酮 XL 对记忆和社会心理功能的影响。41 名(18-50 岁)患有 MDD 的患者参加了为期 8 周的、双盲、双模拟、随机对照比较试验,比较安非他酮 XL 和艾司西酞普兰的疗效。36 名参与者完成了记忆评估的前后测试。采用全面的神经心理测验评估言语、非言语和工作记忆。采用 Sheehan 残疾量表和 Endicott 工作效率量表评估社会心理功能。艾司西酞普兰和安非他酮 XL 均显著改善了即刻和延迟的言语和非言语记忆、总体功能(所有 p≤0.001)和工作效率(p=0.045),且两组间无显著差异。即刻言语记忆的改善对总体功能的改善有直接影响(p=0.006)。艾司西酞普兰或安非他酮 XL 治疗与 MDD 成人的记忆和社会心理功能改善有关。

相似文献

1
The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial.安非他酮 XL 和依地普仑对成年重性抑郁障碍患者记忆和功能结局的影响:一项随机对照试验的结果。
Psychiatry Res. 2014 Dec 15;220(1-2):245-50. doi: 10.1016/j.psychres.2014.06.053. Epub 2014 Jul 10.
2
Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.安非他酮缓释剂与艾司西酞普兰对比:两项随机、双盲、安慰剂对照研究中对性功能及抗抑郁疗效的影响
J Clin Psychiatry. 2006 May;67(5):736-46. doi: 10.4088/jcp.v67n0507.
3
Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial.盐酸安非他酮缓释片与草酸艾司西酞普兰治疗中国抑郁症患者的疗效和安全性:一项随机、双盲、非劣效性试验的结果。
J Affect Disord. 2019 Oct 1;257:143-149. doi: 10.1016/j.jad.2019.07.023. Epub 2019 Jul 5.
4
A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder.一项关于安非他酮缓释片与艾司西酞普兰治疗广泛性焦虑障碍的对照试验。
Psychopharmacol Bull. 2008;41(1):46-51.
5
Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.一种定量脑电图生物标志物在预测重度抑郁症患者对艾司西酞普兰和安非他酮的不同反应或缓解情况方面的有效性。
Psychiatry Res. 2009 Sep 30;169(2):132-8. doi: 10.1016/j.psychres.2009.04.004. Epub 2009 Aug 26.
6
An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.艾司西酞普兰与安非他酮缓释剂联合治疗重度抑郁症门诊患者的开放性初步研究。
J Psychiatr Pract. 2008 Sep;14(5):271-80. doi: 10.1097/01.pra.0000336754.19566.65.
7
Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?消极情感性是否能预测对选择性5-羟色胺再摄取抑制剂(SSRI)与非SSRI类抗抑郁药的不同反应?
J Clin Psychiatry. 2014 Sep;75(9):e939-44. doi: 10.4088/JCP.14m09025.
8
Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.重性抑郁障碍的认知-功能关系:文拉法辛与艾司西酞普兰开放标签研究的关键数据来自乌克兰。
J Affect Disord. 2019 May 1;250:114-122. doi: 10.1016/j.jad.2019.03.040. Epub 2019 Mar 5.
9
Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study.用于伴有精力减退、愉悦感缺失及兴趣缺乏症状的重度抑郁症患者的缓释安非他酮:一项随机、双盲、安慰剂对照研究的结果
J Clin Psychiatry. 2006 Jun;67(6):865-73. doi: 10.4088/jcp.v67n0602.
10
Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.艾司西酞普兰和度洛西汀治疗重度抑郁症:一项使用英国成本数据的药物经济学比较。
Pharmacoeconomics. 2008;26(11):969-81. doi: 10.2165/00019053-200826110-00008.

引用本文的文献

1
The pCREB/BDNF Pathway in the Hippocampus Is Involved in the Therapeutic Effect of Selective 5-HT Reuptake Inhibitors in Adult Male Rats Exposed to Blast Traumatic Brain Injury.海马体中的pCREB/BDNF信号通路参与了选择性5-羟色胺再摄取抑制剂对遭受爆炸性创伤性脑损伤的成年雄性大鼠的治疗作用。
Brain Sci. 2025 Feb 24;15(3):236. doi: 10.3390/brainsci15030236.
2
A cognitive neural circuit biotype of depression showing functional and behavioral improvement after transcranial magnetic stimulation in the B-SMART-fMRI trial.在B-SMART-fMRI试验中,一种抑郁症的认知神经回路生物型在经颅磁刺激后显示出功能和行为改善。
Nat Ment Health. 2024 Aug;2(8):987-998. doi: 10.1038/s44220-024-00271-9. Epub 2024 Jul 5.
3
Comparing the Efficacy of Escitalopram with and without Crocin in Restoring I/O Functions and LTP within the Hippocampal CA1 Region of Stressed Rats.
比较艾司西酞普兰联合与不联合藏红花恢复应激大鼠海马CA1区输入/输出功能及长时程增强效应的疗效。
Adv Biomed Res. 2024 Nov 30;13:116. doi: 10.4103/abr.abr_18_24. eCollection 2024.
4
The Effect of Antidepressant Treatment on Neurocognitive Functions, Redox and Inflammatory Parameters in the Context of COVID-19.抗抑郁治疗对新冠疫情背景下神经认知功能、氧化还原及炎症参数的影响
J Clin Med. 2023 Nov 12;12(22):7049. doi: 10.3390/jcm12227049.
5
Practical pathway for the management of depression in the workplace: a Canadian perspective.工作场所抑郁症管理的实用路径:加拿大视角
Front Psychiatry. 2023 Sep 5;14:1207653. doi: 10.3389/fpsyt.2023.1207653. eCollection 2023.
6
A Cognitive Biotype of Depression and Symptoms, Behavior Measures, Neural Circuits, and Differential Treatment Outcomes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.抑郁症的认知生物型与症状、行为测量、神经回路和差异化治疗结果:一项随机临床试验的预设二次分析。
JAMA Netw Open. 2023 Jun 1;6(6):e2318411. doi: 10.1001/jamanetworkopen.2023.18411.
7
Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research.抑郁认知障碍的药理学靶向治疗:人类临床研究的最新进展和挑战。
Transl Psychiatry. 2022 Nov 17;12(1):484. doi: 10.1038/s41398-022-02249-6.
8
Comparing the Therapeutic Effects of Crocin, Escitalopram and Co-Administration of Escitalopram and Crocin on Learning and Memory in Rats with Stress-Induced Depression.比较西红花苷、艾司西酞普兰及艾司西酞普兰与西红花苷联合应用对应激性抑郁大鼠学习记忆的治疗作用
Malays J Med Sci. 2021 Aug;28(4):50-62. doi: 10.21315/mjms2021.28.4.6. Epub 2021 Aug 26.
9
Baseline predictors of cognitive change in the treatment of major depressive episode: systematic review.重度抑郁发作治疗中认知变化的基线预测因素:系统评价
BJPsych Open. 2020 Oct 30;6(6):e131. doi: 10.1192/bjo.2020.114.
10
Cognitive Dysfunction in Major Depressive Disorder: Assessment, Impact, and Management.重度抑郁症中的认知功能障碍:评估、影响及管理
Focus (Am Psychiatr Publ). 2016 Apr;14(2):194-206. doi: 10.1176/appi.focus.20150043. Epub 2016 Apr 7.